Insider Trading History of Jacob Gary S

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Jacob Gary S since 2005. This trader's CIK number is 1266802. At the time of last reporting, Jacob Gary S was the Chief Executive Officer of Okyo Pharma Ltd. (stock ticker symbol OKYO). Also see all insider trading activities at Okyo Pharma Ltd.

Note that in the past JACOB GARY S also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Cardiff Oncology, Inc. (CRDF) by Jacob Gary S

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 CRDF 2,370 $24,669 0 $0 0 $0
2020 CRDF 17,483 $25,000 0 $0 0 $0
2018 CRDF 0 $0 0 $0 16,667 $0
2017 CRDF 0 $0 0 $0 9,287 $0

Yearly summary of insider trading at Synergy Pharmaceuticals, Inc. (SGYP) by Jacob Gary S

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 SGYP 0 $0 0 $0 474,961 $237,480
2017 SGYP 5,680 $19,965 0 $0 0 $0
2015 SGYP 0 $0 0 $0 62,965 $353,233
2014 SGYP 4,000 $16,720 0 $0 0 $0

Yearly summary of insider trading at Hepion Pharmaceuticals, Inc. (HEPA) by Jacob Gary S

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 HEPA 12,000 $19,920 0 $0 0 $0

Yearly summary of insider trading at Callisto Pharmaceuticals Inc (KAL) by Jacob Gary S

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2006 KAL 5,000 $4,200 0 $0 0 $0
2005 KAL 21,448 $30,000 0 $0 0 $0

Yearly summary of insider trading at Okyo Pharma Ltd (OKYO) by Jacob Gary S

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 OKYO 12,500 $50,000 0 $0 0 $0

Yearly summary of insider trading at Virpax Pharmaceuticals, Inc. (VRPX) by Jacob Gary S

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 VRPX 3,500 $23,761 0 $0 0 $0


Insider trading activities at 6 companies by Jacob Gary S:

1. Cardiff Oncology, Inc. (CRDF)

2. Synergy Pharmaceuticals, Inc. (SGYP)

3. Hepion Pharmaceuticals, Inc. (HEPA)

4. Callisto Pharmaceuticals Inc (KAL)

5. Okyo Pharma Ltd (OKYO)

6. Virpax Pharmaceuticals, Inc. (VRPX)

Table 1. Insider trading of Cardiff Oncology, Inc. (CRDF) by Jacob Gary S

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-03-23 CRDF Buy 2,370 10.41 24,669
2020-05-14 CRDF Buy 17,483 1.43 25,000
2018-01-02 TROV Option Ex 16,667 .00 0
2017-09-02 TROV Option Ex 9,287 .00 0

Table 2. Insider trading of Synergy Pharmaceuticals, Inc. (SGYP) by Jacob Gary S

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-06-15 SGYP Option Ex 474,961 .50 237,480
2017-05-26 SGYP Buy 5,680 3.52 19,965
2015-07-01 SGYP Option Ex 62,965 5.61 353,233
2014-05-27 SGYP Buy 4,000 4.18 16,720

Table 3. Insider trading of Hepion Pharmaceuticals, Inc. (HEPA) by Jacob Gary S

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-12-01 HEPA Buy 12,000 1.66 19,920

Table 4. Insider trading of Callisto Pharmaceuticals Inc (KAL) by Jacob Gary S

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2006-08-21 KAL Buy 5,000 .84 4,200
2005-06-16 KAL Buy 5,000 1.00 5,000
2005-03-09 KAL Buy 16,448 1.52 25,000

Table 5. Insider trading of Okyo Pharma Ltd (OKYO) by Jacob Gary S

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-05-19 OKYO Buy 12,500 4.00 50,000

Table 6. Insider trading of Virpax Pharmaceuticals, Inc. (VRPX) by Jacob Gary S

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-02-17 VRPX Buy 3,500 6.79 23,761

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Jacob Gary S (Chief Executive Officer of Okyo Pharma Ltd at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.